Cargando…
Refusal of Retreatment With Topical 5-Fluorouracil Among Patients With Actinic Keratosis: Qualitative Analysis
BACKGROUND: Actinic keratosis (AK) is a common premalignant skin lesion, and topical 5-fluorouracil (5-FU) is commonly used in field-directed therapy. However, 5-FU is associated with frequent local skin reactions. OBJECTIVE: This study aimed to qualitatively assess experiences among patients with A...
Autores principales: | Singh, Rohan, McCain, Sarah, Feldman, Steven R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335144/ https://www.ncbi.nlm.nih.gov/pubmed/37632916 http://dx.doi.org/10.2196/39988 |
Ejemplares similares
-
Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment
por: Azin, Marjan, et al.
Publicado: (2022) -
Patient‐reported skin reactions to 5% 5‐fluorouracil in treatment of actinic keratosis
por: Ahmady, S., et al.
Publicado: (2021) -
Real-World Experience With Topical 5-Fluorouracil 4% (40 mg/g) Cream for the Treatment of Actinic Keratosis
por: Briatico, Giulia, et al.
Publicado: (2023) -
Evaluation of the therapeutic results of actinic keratosis treated with
topical 5% fluorouracil by reflectance confocal laser microscopy: preliminary
study
por: Ishioka, Priscila, et al.
Publicado: (2015) -
Patient‐reported outcomes of topical therapies in actinic keratosis: A systematic review
por: Grada, Ayman, et al.
Publicado: (2021)